Myocardial interaction of apixaban after experimental acute volume overload.

Christa HuuskonenMari HämäläinenNooa KivikangasTimo PaavonenEeva MoilanenAri A Mennander

Published in: The Journal of international medical research (2022)

Apixaban interacts with intramyocardial arteries in the left and right ventricles after AVO and ANP and MMP9 expression levels increased. Thus, the myocardial effect of Factor Xa inhibition needs to be monitored after AVO.

Keyphrases

venous thromboembolism
atrial fibrillation
left ventricular
liver failure
poor prognosis
binding protein
respiratory failure
drug induced
hepatitis b virus